AMT’s ELANA® Heart Bypass System, a minimally invasive solution designed to replace traditional open-heart bypass surgery The ...

Beating-heart compatibility: Reduces stroke risks and complications, and potentially over 50% cost reduction with a standardized, reproducible and easy-to-learn technology. EDE/UTRECHT, The ...

A small Chinese trial compared the effects of three oral antispastic medications for 24 weeks post-coronary artery bypass grafting (CABG) in relation to spasm-induced radial artery graft failure.

AMT Medical announced today that it raised $25 million in a Series B financing round to support its Elana heart bypass system ...

Researchers from Philadelphia-based University of Pennsylvania’s Leonard Davis Institute of Health Economics recently found ...

In this randomized clinical trial, the use of near-infrared spectroscopy and hemodynamic monitoring did not provide ...

Jim McIntosh has always known his family history of heart disease put him at risk. His grandfather died of a heart attack at ...

Manhasset, N.Y.-based North Shore University Hospital had the highest 30-day survival rate for coronary artery bypass graft patients among all U.S. hospitals participating in CMS’ Fiscal Year 2025 ...

Jim McIntosh, facilities director at the Rutgers School of Dental Medicine, takes swift action after a warning sign he couldn't ignoreJim McIntosh has ...

Anthony A. Bavry, M.D., M.P.H., F.A.C.C.; Deepak L. Bhatt, M.D., F.A.C.C. Description: The goal of the trial was to evaluate coronary artery revascularization with ...

Researchers sought to determine the effect of COPD exacerbation risk for ASCVD hospitalization in patients with ASCVD.